1 389

Cited 58 times in

Recurrence after curative resection of early gastric cancer.

DC FieldValueLanguage
dc.contributor.author안지영-
dc.date.accessioned2015-04-23T16:39:21Z-
dc.date.available2015-04-23T16:39:21Z-
dc.date.issued2010-
dc.identifier.issn1068-9265-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/100979-
dc.description.abstractBACKGROUND: Few studies have evaluated the recurrence of EGC after curative gastrectomy, due to its relatively low incidence. This study evaluated recurrence patterns and independent predictive factors for recurrence in order to determine appropriate follow-up and early detection of recurrence. METHODS: We reviewed the medical records of 3,883 consecutive patients who underwent curative gastrectomy for EGC at Samsung Medical Center between February 1995 and January 2006 and were followed up until January 2008. The clinical and pathological characteristics and the predictive factors for recurrence were evaluated retrospectively. RESULTS: Eighty-five (2.2%) patients had recurrence, and liver was the most common site of recurrence (45.9%). The recurrence rates within 2, 3, and 5 years were 43.5%, 67.1%, and 85.6%, respectively. There were 106 overall recurrences, with 86 (81.1%) being detected by computed tomography (CT). Second primary cancer was the primary cause of death after gastrectomy, followed by recurrence. Old age (>60 years), tumor size (>3 cm), multiple tumor, N category, and N2 station metastasis were significant factors for recurrence by multivariate analysis, but depth of invasion was not a significant factor. CONCLUSIONS: Age, tumor size, number of tumors, N category, and N2 station metastasis were predictive factors for recurrence, with lymph node metastasis being the most significant factor. After curative gastrectomy, follow-up programs should be applied for more than 5 years for EGC patients, and computed tomography could be an essential diagnostic tool.-
dc.description.statementOfResponsibilityopen-
dc.format.extent448~454-
dc.relation.isPartOfANNALS OF SURGICAL ONCOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHFemale-
dc.subject.MESHFollow-Up Studies-
dc.subject.MESHGastrectomy*-
dc.subject.MESHHumans-
dc.subject.MESHLung Neoplasms/secondary*-
dc.subject.MESHLymphatic Metastasis-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHNeoplasm Recurrence, Local/etiology*-
dc.subject.MESHNeoplasm Staging-
dc.subject.MESHNeoplasms, Second Primary*-
dc.subject.MESHRetrospective Studies-
dc.subject.MESHRisk Factors-
dc.subject.MESHStomach Neoplasms/pathology-
dc.subject.MESHStomach Neoplasms/surgery*-
dc.subject.MESHSurvival Rate-
dc.subject.MESHTreatment Outcome-
dc.titleRecurrence after curative resection of early gastric cancer.-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Surgery (외과학)-
dc.contributor.googleauthorHo Geun Youn-
dc.contributor.googleauthorJi Yeong An-
dc.contributor.googleauthorMin Gew Choi-
dc.contributor.googleauthorJae Hyung Noh-
dc.contributor.googleauthorTae Sung Sohn-
dc.contributor.googleauthorSung Kim-
dc.identifier.doi10.1245/s10434-009-0772-2-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA02264-
dc.relation.journalcodeJ00179-
dc.identifier.eissn1534-4681-
dc.identifier.pmid19904573-
dc.identifier.urlhttp://link.springer.com/article/10.1245%2Fs10434-009-0772-2-
dc.subject.keywordGastric Cancer-
dc.subject.keywordPositron Emission Tomography-
dc.subject.keywordPrimary Cancer-
dc.subject.keywordAdvanced Gastric Cancer-
dc.subject.keywordChest Radiography-
dc.contributor.alternativeNameAn, Ji Yeong-
dc.contributor.affiliatedAuthorAn, Ji Yeong-
dc.citation.volume17-
dc.citation.number2-
dc.citation.startPage448-
dc.citation.endPage454-
dc.identifier.bibliographicCitationANNALS OF SURGICAL ONCOLOGY, Vol.17(2) : 448-454, 2010-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.